ATE74768T1 - Feste pharmazeutische zubereitung und verfahren zur herstellung derselben. - Google Patents

Feste pharmazeutische zubereitung und verfahren zur herstellung derselben.

Info

Publication number
ATE74768T1
ATE74768T1 AT89110019T AT89110019T ATE74768T1 AT E74768 T1 ATE74768 T1 AT E74768T1 AT 89110019 T AT89110019 T AT 89110019T AT 89110019 T AT89110019 T AT 89110019T AT E74768 T1 ATE74768 T1 AT E74768T1
Authority
AT
Austria
Prior art keywords
same
pharmaceutical preparation
solid pharmaceutical
making
preparation
Prior art date
Application number
AT89110019T
Other languages
English (en)
Inventor
Tadashi Makino
Koji Doi
Masayoshi Matsuoka
Toshiharu Tsuboi
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE74768T1 publication Critical patent/ATE74768T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT89110019T 1988-06-03 1989-06-02 Feste pharmazeutische zubereitung und verfahren zur herstellung derselben. ATE74768T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63137925A JPH01308232A (ja) 1988-06-03 1988-06-03 固型医薬およびその製造法
EP89110019A EP0348688B1 (de) 1988-06-03 1989-06-02 Feste pharmazeutische Zubereitung und Verfahren zur Herstellung derselben

Publications (1)

Publication Number Publication Date
ATE74768T1 true ATE74768T1 (de) 1992-05-15

Family

ID=15209888

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89110019T ATE74768T1 (de) 1988-06-03 1989-06-02 Feste pharmazeutische zubereitung und verfahren zur herstellung derselben.

Country Status (8)

Country Link
US (1) US5017564A (de)
EP (1) EP0348688B1 (de)
JP (1) JPH01308232A (de)
KR (1) KR910000163A (de)
AT (1) ATE74768T1 (de)
DE (1) DE68901216D1 (de)
ES (1) ES2032628T3 (de)
GR (1) GR3004440T3 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2634374B1 (fr) * 1988-07-19 1993-10-15 Laboratoires Serobiologiques Agents photoprotecteurs, cytophotoprotecteurs cutanes ayant une activite photoprotectrice des cellules constitutives, fonctionnelles de la peau, en particulier des cellules de langerhans, a base de composes nucleiques : nucleoprotides, ribonucleotides et desoxyribonucleotides, ribonucleosides et desoxyribonucleosides, compositions cosmetiques ou dermo-pharmaceutiques contenant un tel agent ainsi que des nouveaux composes en soi
US7348315B2 (en) 1995-03-23 2008-03-25 The University Of Connecticut Methods of treating heart failure with modified ATP, ADP and AMP compounds
US5712258A (en) * 1995-03-23 1998-01-27 The Trustees Of The University Of Pennsylvania Inotropic ADP and ATP analogues and their pharmaceutical compositions
US6723737B1 (en) * 1999-10-20 2004-04-20 Eliezer Rapaport Methods, pharmaceutical and therapeutic compostions for administering adenosine
WO2001028528A1 (en) * 1999-10-20 2001-04-26 Eliezer Rapaport Methods, pharmaceutical and therapeutic compositions for administering adenosine
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20030069203A1 (en) * 2001-06-04 2003-04-10 Lee Steve S. Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate
JP2003119139A (ja) * 2001-10-12 2003-04-23 Ss Pharmaceut Co Ltd 疲労回復医薬組成物
US6585996B1 (en) 2002-03-13 2003-07-01 Westlake Laboratories, Inc. Lipid-soluble thiamine derivatives in the treatment of autism
US20050070701A1 (en) * 2003-09-29 2005-03-31 Hochstetler Spencer Erich Detection of living cells in polymers or pigments
ITMI20041772A1 (it) * 2004-09-17 2004-12-17 Bioprogress Spa Formulazione a rilascio controllato di tiamina e loro impiego nel trattamento di patologie collegate a difetti nei processi di apprendimento e memorizzazione.
CN101184496A (zh) * 2005-05-27 2008-05-21 兴和株式会社 用于恢复疲劳的药品
TW200812601A (en) * 2006-05-30 2008-03-16 Kowa Co Medicine for recovering from fatigue
JP5114399B2 (ja) * 2006-06-27 2013-01-09 興和株式会社 疲労予防及び／又は回復のための医薬
US20210369708A1 (en) * 2018-11-02 2021-12-02 Kyungpook National University Industry-Academic Cooperation Foundation Composition for prevention or treatment of macular degeneration
EP3965744A1 (de) * 2019-05-06 2022-03-16 Ferrer Internacional, S.A. Mehrschichtige pharmazeutische oder nutrazeutische feste darreichungsformen mit pyrimidin- und/oder purinderivaten und b-vitaminen, deren herstellung und verwendungen

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2775521A (en) * 1953-09-29 1956-12-25 Hoffmann La Roche Method of fortifying grain products and the resulting product
US3037911A (en) * 1959-09-04 1962-06-05 Merck & Co Inc Chewable, palatable, vitamin b preparations
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets
SE352811B (de) * 1971-06-04 1973-01-15 Pharmacia Ab
GB1431841A (en) * 1973-01-15 1976-04-14 Evans S C Ophthalmic-nutritional preparations
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
FR2358155A1 (fr) * 1976-07-15 1978-02-10 Lapinet Eugene Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses
US4382924A (en) * 1980-06-25 1983-05-10 The Procter & Gamble Company Palatable composition containing oil or oil-like materials
FR2557452B1 (fr) * 1983-12-28 1986-08-14 Roussel Uclaf Nouvelles compositions pour les soins de la peau renfermant de l'huile d'onagre et des traits tissulaires de rate
US4713245A (en) * 1984-06-04 1987-12-15 Mitsui Toatsu Chemicals, Incorporated Granule containing physiologically-active substance, method for preparing same and use thereof
US4764388A (en) * 1985-01-25 1988-08-16 Nabisco Brands, Inc. Method for making vitamin enriched cereal
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0816066B2 (ja) * 1986-07-18 1996-02-21 エーザイ株式会社 持続性薬効製剤
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair

Also Published As

Publication number Publication date
EP0348688B1 (de) 1992-04-15
GR3004440T3 (de) 1993-03-31
US5017564A (en) 1991-05-21
EP0348688A1 (de) 1990-01-03
KR910000163A (ko) 1991-01-29
ES2032628T3 (es) 1993-02-16
DE68901216D1 (de) 1992-05-21
JPH01308232A (ja) 1989-12-12

Similar Documents

Publication Publication Date Title
ATE74768T1 (de) Feste pharmazeutische zubereitung und verfahren zur herstellung derselben.
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
DE3575927D1 (de) Purinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
DE58902737D1 (de) Verfahren zur herstellung pharmazeutischer mischungen.
ATE101520T1 (de) Stabilisiertes arzneimittel und verfahren zu dessen herstellung.
ATE123285T1 (de) Antivirale pyrimidin- und purinverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate.
ATE101340T1 (de) Neue arzneimittelformulierung sowie verfahren zu deren herstellung.
DE3485075D1 (de) Pharmazeutische zubereitung zur heilung der erkrankungen der zahnwurzelhaut und verfahren zu deren herstellung.
DE3785198D1 (de) Liposomes praeparat und antibiotikum.
ES2070981T3 (es) Concentrados de componente activo y nuevas combinaciones de componente activo de hojas de ginkgo biloba, sus metodos de preparacion y productos farmaceuticos que contienen los concentrados de componente activo o las combinaciones de componente activo.
HUT52769A (en) Process for producing pyrimidine derivatives and pharmaceutical compositions containing them
ES8707545A1 (es) Un metodo para preparar compuestos de 2-cloro-2'-desoxiadenosin-5'-fosfato.
DE58900183D1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
ES2045182T3 (es) Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
DE3879873D1 (de) Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
DE3682811D1 (de) Pharmazeutische zusammensetzung zur heilung und verhuetung kardiovaskularer krankheiten und verfahren zu ihrer herstellung.
ATE99945T1 (de) Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln.
ES2054738T3 (es) Derivados de acido 3-desmetil-4-fluoromevalonico, procedimiento para su preparacion, preparados farmaceuticos a base de estos compuestos, su empleo y productos intermedios.
FI861655A (fi) Menetelmä lääkeaineina käyttökelpoisten griseoliinihapon johdannaisten valmistamiseksi
PT89802A (pt) Processo para a preparacao de uma composicao farmaceutica, contendo o factor xiii de coagulacao do sangue humano, para a prevencao da hemorragia intraventricular em criancas permaturas
IT8921893A0 (it) Procedimento per la produzione di impiallacciatura artificiale ad imitazione della radica, mediante bruciature.
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
DE69103624D1 (de) Ipriflavone enthaltende pharmazeutische zubereitungen, verfahren zur herstellung und therapeutische verwendung.
FR2639830B1 (fr) Composition antivirale et ses applications

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee